Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.3K
Overview
45.3K
Immunological Memory01:23

Immunological Memory

4.7K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
4.7K
Active versus Passive Immunity01:31

Active versus Passive Immunity

3.6K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
3.6K
Humoral Immune Responses01:36

Humoral Immune Responses

75.5K
Overview
75.5K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

665
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
665

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidental Detection of Coronary Artery Calcification in Women Undergoing Cancer Screening or Treatment.

Current atherosclerosis reports·2026
Same author

Folic Acid-Conjugated PLGA Nanoparticles of Eugenol: Development, Characterization, and In Vitro Cytotoxicity Studies on Breast Cancer Cell Line.

BioMed research international·2026
Same author

Divergent inflammatory and neurology-related protein levels in long COVID following primary and breakthrough SARS-CoV-2 infections.

Communications medicine·2026
Same author

Quality by design in parenteral drug development: addressing formulation challenges and industrial insights.

Drug development and industrial pharmacy·2026
Same author

Revolutionizing cancer treatment with senotherapeutics: a current perspective.

Cancer chemotherapy and pharmacology·2026
Same author

Systematic review protocol: evaluation of candidate platforms and vaccines for emerging and re-emerging viral threats.

Systematic reviews·2026
Same journal

Unveiling the Potential of Drug Delivery Systems for Tyrosine Kinase Inhibitors in the Treatment of Neovascular Eye Diseases.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Investigation of Bioinspired Nanocurcumin Composites for Antibacterial Applications.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Advances in the Preparation of Lipid-Based Nanotechnologies: Expanding the Horizons of Therapeutic Applications.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Nano Lipid Carriers (NLCs): Potential and Promises in Drug Delivery.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

CpG ODNs: Precision Immunotherapy and Recent Trends in Nano-Enabled Nucleotide Delivery.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Plant-Based Exosomes: Insights and Therapeutic Applications.

Critical reviews in therapeutic drug carrier systems·2026
See all related articles

Related Experiment Video

Updated: Sep 8, 2025

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.3K

Crafting Immunological Response Using Particulate Vaccines.

Amit Bansal1, Bernadette D'Souza2, Deepak N Kapoor3

  • 1Formulation Research & Development, Perrigo, Allegan, MI 49009.

Critical Reviews in Therapeutic Drug Carrier Systems
|June 13, 2022
PubMed
Summary
This summary is machine-generated.

Particulate vaccines enhance immune responses by delivering antigens effectively and acting as adjuvants. Nanocarriers are crucial for developing scalable COVID-19 vaccines for global distribution.

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.3K
Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

14.6K

Related Experiment Videos

Last Updated: Sep 8, 2025

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.3K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.3K
Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

14.6K

Area of Science:

  • Immunology
  • Vaccinology
  • Nanotechnology

Background:

  • Particulate vaccines offer advantages like targeted antigen delivery, protection from degradation, and sustained release, mimicking viral structures to act as adjuvants.
  • Adjuvants are essential for improving vaccine immunogenicity, especially for subunit vaccines, by providing necessary danger signals and enabling antigen dose sparing.
  • Various particulate carriers, including virus-like particles, liposomes, immunostimulating complexes, and polymeric particles, are explored for vaccine antigen delivery.

Purpose of the Study:

  • To review the role of particulate vaccines in enhancing immunogenicity and explore their advantages as antigen delivery vehicles.
  • To discuss the impact of particle properties (size, shape, rigidity) on immunological outcomes and cellular interactions.
  • To highlight the relevance of nanocarriers in developing effective immunization strategies for current and future pandemics, such as COVID-19.

Main Methods:

  • Literature review of particulate vaccine technology and antigen delivery systems.
  • Discussion of particle characteristics influencing immune response and cellular uptake mechanisms.
  • Analysis of the importance of vaccine stability, storage conditions, and scalability for global vaccination efforts.

Main Results:

  • Particulate vaccines demonstrate potential for optimal immunogenicity, antigen dose sparing, and controlled release.
  • Particle properties significantly influence cellular uptake, antigen processing, and presentation by antigen-presenting cells.
  • Nanocarriers are identified as highly relevant for developing scalable and effective immunization strategies, particularly for the SARS-CoV-2 pandemic.

Conclusions:

  • Particulate vaccine systems offer a promising platform for enhancing immune responses and overcoming challenges associated with traditional vaccines.
  • Understanding particle properties and cellular interactions is key to designing effective particulate vaccines.
  • Nanocarrier-based vaccine development is critical for addressing global health challenges and ensuring rapid, scalable vaccination during pandemics like COVID-19.